724P - Post-hoc analyses of a subgroup of patients with advanced biliary tract cancer (BTC) who crossed over to treatment with etoposide toniribate (EDO-S7.1) in a randomized phase II study
| Autor: | Pape, U.-F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Mueller, L., Burkhard, O., Caca, K., Heeg, S., Rodriguez Laval, V., Kuhl, A.A., Arsenic, R., Jansen, H., Mehrling, T., Hilgier, K., Wagner, I., Utku, N. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v278-v278 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|